Stock Ratings | Guggenheim raises SCYNEXIS (SCYX) target to $33 with potential upside of 544.53%; Barclays raises CoreWeave (CRWV) target to $105
SCYNEXIS, Inc. SCYX | 0.00 | |
Kura Oncology, Inc. KURA | 0.00 | |
Inovio Pharmaceuticals, Inc. INO | 0.00 | |
Polaryx Therapeutics, Inc. PLYX | 0.00 | |
PDS Biotechnology Corp. PDSB | 0.00 |
The ratings of major US investment banks are used to track the latest valuations and target prices on Wall Street daily, and to explore potential equity investment opportunities.
Risk warning:
Investing in small-cap stocks can be risky. Be prepared for potential challenges related to liquidity, high volatility, limited information, and financial instability. Always diversify your investments.
Today's key assessments and concerns
Guggenheim: Maintaining a "buy" rating on Scynexis ( SCYNEXIS, Inc.(SCYX.US) ), while raising its price target from $24 to $33.
Wedbush: Maintaining its "Outperform Market" rating for Kura Oncology ( Kura Oncology, Inc.(KURA.US) ), while raising its price target from $36 to $38.
Jefferies: Upgraded Inovio Pharmaceuticals ( Inovio Pharmaceuticals, Inc.(INO.US) ) to "Buy", raising the price target from $1.8 to $3.
Raymond James: Initial rating for Polaryx Therapeutics ( Polaryx Therapeutics, Inc.(PLYX.US) ) at "Strong Buy", with a price target of $6.
HC Wainwright & Co.: Maintaining a "buy" rating on PDS Biotechnology ( PDS Biotechnology Corp.(PDSB.US) ), while lowering the price target from $15 to $7.
| The symbol | Classification | Target price | Current price | Percentage of potential increase/decrease | (Classification) Agency |
| SCYNEXIS, Inc.(SCYX.US) | to lift | $33.0 | $5.12 | 544.53% | Guggenheim |
| Kura Oncology, Inc.(KURA.US) | to lift | $38.0 | $10.09 | 276.61% | Wedbush |
| Inovio Pharmaceuticals, Inc.(INO.US) | to lift | $3.0 | $0.9001 | 233.3% | Jefferies |
| MoonLake Immunotherapeutics Class A(MLTX.US) | to lift | $50.0 | $16.5 | 203.03% | HC Wainwright & Co. |
| USIO INC(USIO.US) | to lift | $6.75 | $2.59 | 160.62% | Ladenburg Thalmann |
| Polaryx Therapeutics, Inc.(PLYX.US) | Initial classification | $6.0 | $2.5 | 140.0% | Raymond James |
| PDS Biotechnology Corp.(PDSB.US) | cut | $7.0 | $0.2332 | 2901.72% | HC Wainwright & Co. |
| Vertical Aerospace Ltd.(EVTL.US) | cut | $5.0 | $0.8379 | 496.73% | Needham |
| Unicycive Therapeutics(UNCY.US) | cut | $25.0 | $5.4 | 362.96% | Jefferies |
| Microvast(MVST.US) | cut | $4.0 | $0.8874 | 350.76% | HC Wainwright & Co. |
comments:
Target price unit and current price: US Dollar;
Current price: As of the latest closing price of US stocks;
Potential percentage increase/potential decrease = (Agency target price - current price) / current price 100% (Current price = Last closing price up to the time of the count)
Lifting
B. Riley Securities: Maintaining a "neutral" rating on Coherent Coherent Corp.(COHR.US) ) stock, while raising the price target from $309 to $345.
Barclays: Maintaining a "Market-Similar Weight" rating for CoreWeave ( CoreWeave(CRWV.US) ), while raising its price target from $90 to $105.
Truist Securities: Maintaining a "buy" rating on Cisco ( Cisco Systems, Inc.(CSCO.US) ) stock, while raising the price target from $125 to $140.
RBC Capital: Maintaining its "Outperform" rating for MongoDB MongoDB, Inc. Class A(MDB.US) ), while raising its price target from $395 to $515.
First Coverage
Benchmark: Allegro Microsystems ( Allegro MicroSystems, Inc.(ALGM.US) ) has an initial rating of "buy" on its stock, with a target price of $60.
Oppenheimer: Initial rating for Carriage Services ( Carriage Services Inc.(CSV.US) ) at "outperforms the market", with a price target of $48.
CIBC: Kazia Kazia(KZIA.US) stock has a preliminary "buy" rating, with a target price of $29.
reduction
DA Davidson: Maintaining a "neutral" rating on CAVA Group CAVA Group, Inc.(CAVA.US) stock, while lowering the price target from $84 to $75.
Citigroup: Maintaining a "buy" rating on Intuit Intuit Inc.(INTU.US) ) stock, while lowering the price target from $591 to $457.
Truist Securities: Maintaining a "Hold" rating on WEC Energy ( WEC Energy Group Inc(WEC.US) ), while lowering the price target from $122 to $114.
Truist Securities: Maintaining a "buy" rating on Xcel Energy ( Xcel Energy Inc.(XEL.US) ), while lowering the price target from $94 to $88.
Editor's Note: This content was created by Saham's AI-powered SaaS tool and reviewed by our editorial team.
Risk Warning: Investing involves risk. Securities may rise, fall, or become worthless. Investing does not guarantee profits and may result in losses. Past performance is not necessarily indicative of future results. Before making any investment decision, investors should assess their financial situation, investment objectives, experience, risk tolerance, and understand the nature of the investment products and their associated risks. For more details on the nature and risks of each investment product, please read the relevant offering documents carefully. If you have any questions, it is advisable to seek independent professional advice.